Revolution Medicines, Inc. (RVMD)
206.64
+0.75
(+0.36%)
USD |
NASDAQ |
Oct 02, 16:00
206.50
-0.14
(-0.07%)
After-Hours: 20:00
Revolution Medicines Net Income (Quarterly) : -644.37M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -644.37M |
| March 31, 2026 | -453.82M |
| December 31, 2025 | -364.89M |
| September 30, 2025 | -305.21M |
| June 30, 2025 | -247.79M |
| March 31, 2025 | -213.42M |
| December 31, 2024 | -194.57M |
| September 30, 2024 | -156.29M |
| June 30, 2024 | -133.23M |
| March 31, 2024 | -116.00M |
| December 31, 2023 | -161.54M |
| September 30, 2023 | -108.43M |
| June 30, 2023 | -98.30M |
| March 31, 2023 | -68.10M |
| December 31, 2022 | -56.51M |
| September 30, 2022 | -73.33M |
| Date | Value |
|---|---|
| June 30, 2022 | -61.22M |
| March 31, 2022 | -57.65M |
| December 31, 2021 | -52.68M |
| September 30, 2021 | -52.94M |
| June 30, 2021 | -44.30M |
| March 31, 2021 | -37.18M |
| December 31, 2020 | -34.20M |
| September 30, 2020 | -27.22M |
| June 30, 2020 | -27.22M |
| March 31, 2020 | -19.52M |
| December 31, 2019 | -14.60M |
| September 30, 2019 | -12.82M |
| June 30, 2019 | -10.12M |
| March 31, 2019 | -10.13M |
| December 31, 2018 | -11.34M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Moderna, Inc. | -782.00M |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Intellia Therapeutics, Inc. | -106.63M |
| Beam Therapeutics, Inc. | -122.68M |
| Prime Medicine, Inc. | -42.11M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 644.37M |
| EPS Diluted (Quarterly) | -3.055 |
| Enterprise Value | 41.52B |
| Earnings Yield | -4.27% |
| Normalized Earnings Yield | -3.973 |